노로바이러스 진단 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Persistence Market Research has recently published an extensive report on the global Norovirus Diagnostics Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

• Norovirus Diagnostics Market Size (2024E): USD 63.8 Million
• Projected Market Value (2033F): USD 134 Million
• Global Market Growth Rate (CAGR 2024 to 2033): 8.6%

Norovirus Diagnostics Market - Report Scope:

The Norovirus Diagnostics Market encompasses a variety of techniques and devices used to accurately diagnose norovirus infections, which are a leading cause of acute gastroenteritis globally. These diagnostic methods are critical for ensuring timely and accurate detection of the virus, enabling appropriate treatment and preventing outbreaks. The market serves diverse segments, including hospitals, diagnostic laboratories, and point-of-care testing facilities. Growth is driven by the increasing incidence of norovirus outbreaks, advancements in diagnostic technologies, and the expanding application of rapid diagnostic tests across various healthcare settings.

Market Growth Drivers:

Several key factors are driving the global Norovirus Diagnostics Market. The rising incidence of norovirus infections globally boosts the market's growth as more patients require accurate and timely diagnosis. Technological advancements in diagnostic techniques, such as the development of rapid antigen detection tests and molecular diagnostics, have improved the precision and speed of norovirus detection, further fueling market expansion. Additionally, the growing awareness of norovirus-related health risks and the increasing implementation of infection control measures drive demand. Enhanced research and development activities, along with the introduction of innovative diagnostic devices, contribute to market growth by offering more tailored solutions for healthcare providers and patients.

Market Restraints:

Despite promising growth prospects, the Norovirus Diagnostics Market faces challenges related to the high costs of advanced diagnostic techniques and the potential risks associated with false-negative results. Market growth can be hindered by the availability of alternative diagnostic solutions, such as clinical diagnosis based on symptoms, which may be preferred by some healthcare providers due to their simplicity. Additionally, concerns about the accessibility of advanced diagnostic methods in low-resource settings pose challenges for market expansion. Addressing these issues requires ongoing investment in research and development to improve the accuracy, affordability, and accessibility of norovirus diagnostics.

Market Opportunities:

The market presents significant opportunities driven by the increasing adoption of molecular diagnostics and rapid antigen detection tests, which offer improved accuracy and speed in norovirus detection. The development of advanced diagnostic technologies, such as multiplex assays and next-generation sequencing, caters to the growing need for more precise and comprehensive diagnostic options. The expansion of healthcare infrastructure in emerging markets provides new channels for market growth, allowing companies to reach a broader patient population and offer access to cutting-edge diagnostic methods. Strategic partnerships, investments in training programs for healthcare professionals, and the introduction of patient-centered approaches are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Norovirus Diagnostics Market globally?
• Which types and techniques of norovirus diagnostics are leading the adoption in various healthcare settings?
• How are technological advancements influencing the competitive landscape of the Norovirus Diagnostics Market?
• Who are the key players in the Norovirus Diagnostics Market, and what strategies are they employing to stay competitive?
• What are the emerging trends and future prospects in the global Norovirus Diagnostics Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Norovirus Diagnostics Market, including BioMerieux SA, DiaSorin S.p.A., and Luminex Corporation, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced diagnostic solutions and explore new detection technologies. Collaborations with healthcare providers, research institutions, and technology developers facilitate market access and promote new product adoption. Emphasis on patient education, high-quality products, and comprehensive training programs fosters market growth and enhances brand loyalty in the evolving Norovirus Diagnostics Market landscape.

Key Companies Profiled:

• Abbott
• R-Biopharm AG
• Cepheid
• Luminex Corporation
• Meridian Bioscience
• ELITechGroup
• Biomerieux SA
• CerTest Biotec S.L.
• Elisabeth Pharmacon, Spol. S Ro
• Qiagen
• Altona Diagnostics GmbH
• Eiken Chemical Co

Norovirus Diagnostics Market Industry Segmentation

By Product

• Rapid Test Kits
• PCR Kits
• ELISA based kits

By End-User

• Hospitals
• Diagnostics Labs
• Clinics

Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption Analysis
• 4.2. Key Regulations
• 4.3. Recent Product launches/ Approvals
• 4.4. PESTEL Analysis
• 4.5. Key Promotional Strategies, By Key Players
• 4.6. Porter's Analysis
• 4.7. Value Chain Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Outlook
  • 5.1.3. Global Viral Testing Diagnostic Kits Market Outlook
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Rising prevalence of Norovirus
  • 5.2.2. Increasing Demand for Rapid Testing
  • 5.2.3. Technological Advancement
  • 5.2.4. Awareness and growing government funding
  • 5.2.5. Rising initiatives by public and private organizations
  • 5.2.6. Growth of Norovirus Diagnostics Centers
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Product
  • 6.1.2. By End User
  • 6.1.3. By Country
• 6.2. 2022 Market Scenario

7. Global Norovirus Diagnostics Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, By Product

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Mn) Analysis By Product, 2019-2023
• 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2024-2033
  • 8.3.1. Rapid Test Kits
  • 8.3.2. PCR Kits
  • 8.3.3. ELISA based kits
• 8.4. Market Attractiveness Analysis By Product

9. Global Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, By End User

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
• 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
  • 9.3.1. Hospitals
  • 9.3.2. Diagnostics laboratories
  • 9.3.3. Clinics
• 9.4. Market Attractiveness Analysis By End User

10. Global Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 10.1. Introduction
• 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
• 10.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, By Region, 2024-2033
  • 10.3.1. North America
  • 10.3.2. Latin America
  • 10.3.3. Europe
  • 10.3.4. East Asia
  • 10.3.5. South Asia
  • 10.3.6. Oceania
  • 10.3.7. Middle East and Africa (MEA)
• 10.4. Market Attractiveness Analysis By Region

11. North America Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

• 11.1. Introduction
• 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 11.3.1. By Country
    • 11.3.1.1. U.S.
    • 11.3.1.2. Canada
  • 11.3.2. By Product
  • 11.3.3. By End User
• 11.4. Market Attractiveness Analysis
  • 11.4.1. By Country
  • 11.4.2. By Product
  • 11.4.3. By End User
• 11.5. Market Trends
• 11.6. Drivers and Restraints - Impact Analysis
• 11.7. Key Players - Intensity Mapping
• 11.8. Country Level Analysis & Forecast
  • 11.8.1. U.S. Norovirus Diagnostics Market Analysis
    • 11.8.1.1. Introduction
    • 11.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 11.8.1.2.1. By Product
      • 11.8.1.2.2. By End User
  • 11.8.2. Canada Norovirus Diagnostics Market Analysis
    • 11.8.2.1. Introduction
    • 11.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 11.8.2.2.1. By Product
      • 11.8.2.2.2. By End User

12. Latin America Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 12.3.1. By Country
    • 12.3.1.1. Mexico
    • 12.3.1.2. Brazil
    • 12.3.1.3. Argentina
    • 12.3.1.4. Rest of Latin America
  • 12.3.2. By Product
  • 12.3.3. By End User
• 12.4. Market Attractiveness Analysis
  • 12.4.1. By Country
  • 12.4.2. By Product
  • 12.4.3. By End User
• 12.5. Market Trends
• 12.6. Drivers and Restraints - Impact Analysis
• 12.7. Key Players - Intensity Mapping
• 12.8. Country Level Analysis & Forecast
  • 12.8.1. Mexico Norovirus Diagnostics Market Analysis
    • 12.8.1.1. Introduction
    • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 12.8.1.2.1. By Product
      • 12.8.1.2.2. By End User
  • 12.8.2. Brazil Norovirus Diagnostics Market Analysis
    • 12.8.2.1. Introduction
    • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 12.8.2.2.1. By Product
      • 12.8.2.2.2. By End User
  • 12.8.3. Argentina Norovirus Diagnostics Market Analysis
    • 12.8.3.1. Introduction
    • 12.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 12.8.3.2.1. By Product
      • 12.8.3.2.2. By End User

13. Europe Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 13.3.1. By Country
    • 13.3.1.1. Germany
    • 13.3.1.2. Italy
    • 13.3.1.3. France
    • 13.3.1.4. U.K.
    • 13.3.1.5. Spain
    • 13.3.1.6. BENELUX
    • 13.3.1.7. Russia
    • 13.3.1.8. Rest of Europe
  • 13.3.2. By Product
  • 13.3.3. By End User
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Product
  • 13.4.3. By End User
• 13.5. Market Trends
• 13.6. Drivers and Restraints - Impact Analysis
• 13.7. Key Players - Intensity Mapping
• 13.8. Country Level Analysis & Forecast
  • 13.8.1. Germany Norovirus Diagnostics Market Analysis
    • 13.8.1.1. Introduction
    • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.1.2.1. By Product
      • 13.8.1.2.2. By End User
  • 13.8.2. Italy Norovirus Diagnostics Market Analysis
    • 13.8.2.1. Introduction
    • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.2.2.1. By Product
      • 13.8.2.2.2. By End User
  • 13.8.3. France Norovirus Diagnostics Market Analysis
    • 13.8.3.1. Introduction
    • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.3.2.1. By Product
      • 13.8.3.2.2. By End User
  • 13.8.4. U.K. Norovirus Diagnostics Market Analysis
    • 13.8.4.1. Introduction
    • 13.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.4.2.1. By Product
      • 13.8.4.2.2. By End User
  • 13.8.5. Spain Norovirus Diagnostics Market Analysis
    • 13.8.5.1. Introduction
    • 13.8.5.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.5.2.1. By Product
      • 13.8.5.2.2. By End User
  • 13.8.6. BENELUX Norovirus Diagnostics Market Analysis
    • 13.8.6.1. Introduction
    • 13.8.6.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.6.2.1. By Product
      • 13.8.6.2.2. By End User
  • 13.8.7. Russia Norovirus Diagnostics Market Analysis
    • 13.8.7.1. Introduction
    • 13.8.7.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.7.2.1. By Product
      • 13.8.7.2.2. By End User

14. East Asia Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. China
    • 14.3.1.2. Japan
    • 14.3.1.3. South Korea
  • 14.3.2. By Product
  • 14.3.3. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By End User
• 14.5. Market Trends
• 14.6. Drivers and Restraints - Impact Analysis
• 14.7. Key Players - Intensity Mapping
• 14.8. Country Level Analysis & Forecast
  • 14.8.1. China Norovirus Diagnostics Market Analysis
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.1.2.1. By Product
      • 14.8.1.2.2. By End User
  • 14.8.2. Japan Norovirus Diagnostics Market Analysis
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.2.2.1. By Product
      • 14.8.2.2.2. By End User
  • 14.8.3. South Korea Norovirus Diagnostics Market Analysis
    • 14.8.3.1. Introduction
    • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.3.2.1. By Product
      • 14.8.3.2.2. By End User

15. South Asia Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. India
    • 15.3.1.2. Indonesia
    • 15.3.1.3. Malaysia
    • 15.3.1.4. Thailand
    • 15.3.1.5. Rest of South Asia
  • 15.3.2. By Product
  • 15.3.3. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By End User
• 15.5. Market Trends
• 15.6. Drivers and Restraints - Impact Analysis
• 15.7. Key Players - Intensity Mapping
• 15.8. Country Level Analysis & Forecast
  • 15.8.1. India Norovirus Diagnostics Market Analysis
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.1.2.1. By Product
      • 15.8.1.2.2. By End User
  • 15.8.2. Indonesia Norovirus Diagnostics Market Analysis
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.2.2.1. By Product
      • 15.8.2.2.2. By End User
  • 15.8.3. Malaysia Norovirus Diagnostics Market Analysis
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.3.2.1. By Product
      • 15.8.3.2.2. By End User
  • 15.8.4. Thailand Norovirus Diagnostics Market Analysis
    • 15.8.4.1. Introduction
    • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.4.2.1. By Product
      • 15.8.4.2.2. By End User

16. Oceania Norovirus Diagnostics Market 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. Australia
    • 16.3.1.2. New Zealand
  • 16.3.2. By Product
  • 16.3.3. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By End User
• 16.5. Market Trends
• 16.6. Drivers and Restraints - Impact Analysis
• 16.7. Key Players - Intensity Mapping
• 16.8. Country Level Analysis & Forecast
  • 16.8.1. Australia Norovirus Diagnostics Market Analysis
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.1.2.1. By Product
      • 16.8.1.2.2. By End User
  • 16.8.2. New Zealand Norovirus Diagnostics Market Analysis
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.2.2.1. By Product
      • 16.8.2.2.2. By End User

17. Middle East and Africa (MEA) Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. GCC Countries
    • 17.3.1.2. Turkey
    • 17.3.1.3. North Africa
    • 17.3.1.4. South Africa
    • 17.3.1.5. Rest of Middle East and Africa
  • 17.3.2. By Product
  • 17.3.3. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By End User
• 17.5. Market Trends
• 17.6. Drivers and Restraints - Impact Analysis
• 17.7. Key Players - Intensity Mapping
• 17.8. Country Level Analysis & Forecast
  • 17.8.1. GCC Countries Norovirus Diagnostics Market Analysis
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.1.2.1. By Product
      • 17.8.1.2.2. By End User
  • 17.8.2. Turkey Norovirus Diagnostics Market Analysis
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.2.2.1. By Product
      • 17.8.2.2.2. By End User
  • 17.8.3. South Africa Norovirus Diagnostics Market Analysis
    • 17.8.3.1. Introduction
    • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.3.2.1. By Product
      • 17.8.3.2.2. By End User
  • 17.8.4. North Africa Norovirus Diagnostics Market Analysis
    • 17.8.4.1. Introduction
    • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.4.2.1. By Product
      • 17.8.4.2.2. By End User

18. Market Structure Analysis

• 18.1. Market Analysis by Tier of Companies
• 18.2. Market Share Analysis of Top Players
• 18.3. Market Presence Analysis

19. Competition Analysis

• 19.1. Competition Dashboard
• 19.2. Competition Deep Dive
  • 19.2.1. Abbott
    • 19.2.1.1. Overview
    • 19.2.1.2. Product Portfolio
    • 19.2.1.3. Sales Footprint
    • 19.2.1.4. Key Financials
    • 19.2.1.5. SWOT Analysis
    • 19.2.1.6. Strategy Overview
      • 19.2.1.6.1. Marketing Strategy
      • 19.2.1.6.2. Product Strategy
      • 19.2.1.6.3. Channel Strategy
  • 19.2.2. R-Biopharm AG
    • 19.2.2.1. Overview
    • 19.2.2.2. Product Portfolio
    • 19.2.2.3. Sales Footprint
    • 19.2.2.4. Key Financials
    • 19.2.2.5. SWOT Analysis
    • 19.2.2.6. Strategy Overview
      • 19.2.2.6.1. Marketing Strategy
      • 19.2.2.6.2. Product Strategy
      • 19.2.2.6.3. Channel Strategy
  • 19.2.3. Cepheid
    • 19.2.3.1. Overview
    • 19.2.3.2. Product Portfolio
    • 19.2.3.3. Sales Footprint
    • 19.2.3.4. Key Financials
    • 19.2.3.5. SWOT Analysis
    • 19.2.3.6. Strategy Overview
      • 19.2.3.6.1. Marketing Strategy
      • 19.2.3.6.2. Product Strategy
      • 19.2.3.6.3. Channel Strategy
  • 19.2.4. Luminex Corporation
    • 19.2.4.1. Overview
    • 19.2.4.2. Product Portfolio
    • 19.2.4.3. Sales Footprint
    • 19.2.4.4. Key Financials
    • 19.2.4.5. SWOT Analysis
    • 19.2.4.6. Strategy Overview
      • 19.2.4.6.1. Marketing Strategy
      • 19.2.4.6.2. Product Strategy
      • 19.2.4.6.3. Channel Strategy
  • 19.2.5. Meridian Bioscience
    • 19.2.5.1. Overview
    • 19.2.5.2. Product Portfolio
    • 19.2.5.3. Sales Footprint
    • 19.2.5.4. Key Financials
    • 19.2.5.5. SWOT Analysis
    • 19.2.5.6. Strategy Overview
      • 19.2.5.6.1. Marketing Strategy
      • 19.2.5.6.2. Product Strategy
      • 19.2.5.6.3. Channel Strategy
  • 19.2.6. ELITechGroup
    • 19.2.6.1. Overview
    • 19.2.6.2. Product Portfolio
    • 19.2.6.3. Sales Footprint
    • 19.2.6.4. Key Financials
    • 19.2.6.5. SWOT Analysis
    • 19.2.6.6. Strategy Overview
      • 19.2.6.6.1. Marketing Strategy
      • 19.2.6.6.2. Product Strategy
      • 19.2.6.6.3. Channel Strategy
  • 19.2.7. Biomerieux SA
    • 19.2.7.1. Overview
    • 19.2.7.2. Product Portfolio
    • 19.2.7.3. Sales Footprint
    • 19.2.7.4. Key Financials
    • 19.2.7.5. SWOT Analysis
    • 19.2.7.6. Strategy Overview
      • 19.2.7.6.1. Marketing Strategy
      • 19.2.7.6.2. Product Strategy
      • 19.2.7.6.3. Channel Strategy
  • 19.2.8. CerTest Biotec S.L.
    • 19.2.8.1. Overview
    • 19.2.8.2. Product Portfolio
    • 19.2.8.3. Sales Footprint
    • 19.2.8.4. Key Financials
    • 19.2.8.5. SWOT Analysis
    • 19.2.8.6. Strategy Overview
      • 19.2.8.6.1. Marketing Strategy
      • 19.2.8.6.2. Product Strategy
      • 19.2.8.6.3. Channel Strategy
  • 19.2.9. Elisabeth Pharmacon, Spol. S Ro
    • 19.2.9.1. Overview
    • 19.2.9.2. Product Portfolio
    • 19.2.9.3. Sales Footprint
    • 19.2.9.4. Key Financials
    • 19.2.9.5. SWOT Analysis
    • 19.2.9.6. Strategy Overview
      • 19.2.9.6.1. Marketing Strategy
      • 19.2.9.6.2. Product Strategy
      • 19.2.9.6.3. Channel Strategy
  • 19.2.10. Qiagen
    • 19.2.10.1. Overview
    • 19.2.10.2. Product Portfolio
    • 19.2.10.3. Sales Footprint
    • 19.2.10.4. Key Financials
    • 19.2.10.5. SWOT Analysis
    • 19.2.10.6. Strategy Overview
      • 19.2.10.6.1. Marketing Strategy
      • 19.2.10.6.2. Product Strategy
      • 19.2.10.6.3. Channel Strategy
  • 19.2.11. Altona Diagnostics GmbH
    • 19.2.11.1. Overview
    • 19.2.11.2. Product Portfolio
    • 19.2.11.3. Sales Footprint
    • 19.2.11.4. Key Financials
    • 19.2.11.5. SWOT Analysis
    • 19.2.11.6. Strategy Overview
      • 19.2.11.6.1. Marketing Strategy
      • 19.2.11.6.2. Product Strategy
      • 19.2.11.6.3. Channel Strategy
  • 19.2.12. Eiken Chemical Co
    • 19.2.12.1. Overview
    • 19.2.12.2. Product Portfolio
    • 19.2.12.3. Sales Footprint
    • 19.2.12.4. Key Financials
    • 19.2.12.5. SWOT Analysis
    • 19.2.12.6. Strategy Overview
      • 19.2.12.6.1. Marketing Strategy
      • 19.2.12.6.2. Product Strategy
      • 19.2.12.6.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology